ALKBH5 and pancreatic neoplasm: The eraser ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 through m6A abolishment, decreasing WIF-1 RNA methylation and mediating Wnt signaling (10, 11).